Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Antiaging Quantum Living (AAQL) EBITDA (2020 - 2025)

Historic EBITDA for Antiaging Quantum Living (AAQL) over the last 6 years, with Q4 2025 value amounting to -$249021.0.

  • Antiaging Quantum Living's EBITDA fell 13978.22% to -$249021.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$639165.0, marking a year-over-year increase of 1917.6%. This contributed to the annual value of -$716847.0 for FY2025, which is 7468.61% down from last year.
  • Antiaging Quantum Living's EBITDA amounted to -$249021.0 in Q4 2025, which was down 13978.22% from -$64371.0 recorded in Q3 2025.
  • Antiaging Quantum Living's EBITDA's 5-year high stood at -$1520.0 during Q3 2022, with a 5-year trough of -$258428.0 in Q1 2024.
  • Its 5-year average for EBITDA is -$87768.1, with a median of -$29727.0 in 2023.
  • Its EBITDA has fluctuated over the past 5 years, first surged by 8008.39% in 2022, then plummeted by 347290.2% in 2024.
  • Antiaging Quantum Living's EBITDA (Quarter) stood at -$19310.0 in 2021, then soared by 64.93% to -$6772.0 in 2022, then plummeted by 1344.61% to -$97829.0 in 2023, then fell by 6.16% to -$103853.0 in 2024, then tumbled by 139.78% to -$249021.0 in 2025.
  • Its EBITDA stands at -$249021.0 for Q4 2025, versus -$64371.0 for Q3 2025 and -$141309.0 for Q2 2025.